abstract |
(57) The present invention relates to a compound of the general formula (I) wherein A, B, D, E, K, G, Z, R 3 and R 5 are defined as ) And pharmaceutically acceptable salts of such compounds. Compound (I) is an adrenocorticotropic hormone releasing factor (hormone) CRF (CRH) antagonist. |